# Is The DEA Still Stuck In The Reefer Madness Era? About Weed! | Cbd Oil Lotion Whole Foods > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/dea-cannabis-policy-updates-patient-access/ > **Published:** 2026-04-12T21:03:58-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:20:39-04:00 > **Clinical Summary:** Explore DEA cannabis policy updates and their impact on patient access and clinical research in the evolving regulatory landscape. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PolicyDeaRegulationAccessResearch Why This Matters The DEA’s scheduling decisions directly impact patient access to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) opportunities. Understanding regulatory positioning helps clinicians navigate patient care within current legal frameworks. Clinical Perspective 🧠 Clinicians should stay informed about federal policy changes that may affect patient access or research opportunities. Continue focusing on patient safety and symptom management within current legal frameworks while advocating for evidence-based policy reform. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Is%20The%20DEA%20Still%20Stuck%20In%20The%20Reefer%20Madness%20Era%3F%20About%20Weed%21%20%7C%20Cbd%20Oil%20Lotion%20W...%20%40drcaplan&url=https%3A//fathomjournal.org/jl06h7ar-ogac-vmcbdktb-xqty-uyfq)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//fathomjournal.org/jl06h7ar-ogac-vmcbdktb-xqty-uyfq)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Is%20The%20DEA%20Still%20Stuck%20In%20The%20Reefer%20Madness%20Era%3F%20About%20Weed%21%20%7C%20Cbd%20Oil%20Lotion%20W...%20--%20via%20%40drcaplan.bsky.social%20https%3A//fathomjournal.org/jl06h7ar-ogac-vmcbdktb-xqty-uyfq)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://fathomjournal.org/jl06h7ar-ogac-vmcbdktb-xqty-uyfq](https://fathomjournal.org/jl06h7ar-ogac-vmcbdktb-xqty-uyfq) Table of Contents - [FAQ](#FAQ)[What type of cannabis news is being reported?](#What_type_of_cannabis_news_is_being_reported) - [What is the clinical relevance rating for this news?](#What_is_the_clinical_relevance_rating_for_this_news) - [Which regulatory agency is involved in this cannabis news?](#Which_regulatory_agency_is_involved_in_this_cannabis_news) - [What areas of cannabis policy does this news cover?](#What_areas_of_cannabis_policy_does_this_news_cover) - [Why should healthcare professionals pay attention to this news?](#Why_should_healthcare_professionals_pay_attention_to_this_news) - [Related](#Related) ## FAQ #### What type of cannabis news is being reported? This appears to be cannabis policy and regulatory news with notable clinical interest. The content is categorized as emerging findings or policy developments that warrant close monitoring by healthcare professionals. #### What is the clinical relevance rating for this news? The news has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This suggests the information contains emerging findings or policy developments worth monitoring closely. #### Which regulatory agency is involved in this cannabis news? The DEA (Drug Enforcement Administration) is tagged as a key component of this news story. This indicates the news likely involves federal drug enforcement policy or regulatory changes. #### What areas of cannabis policy does this news cover? Based on the tags, this news covers policy, DEA regulation, and access issues related to cannabis. These areas suggest potential changes to federal cannabis enforcement or patient access policies. #### Why should healthcare professionals pay attention to this news? The clinical relevance rating indicates this contains emerging findings or policy developments worth monitoring closely. Changes in DEA policy and cannabis access regulations can directly impact patient care and clinical practice. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [The Great Misclassification Caper: Why The Confusion Persists – Fathom Journal](https://cedclinic.com/cannabis-classification-challenges-medical-research/) Explore the ongoing confusion in cannabis classification and its implications for policy and clinical practice. [Read More](https://cedclinic.com/cannabis-classification-challenges-medical-research/) [Justice Department Reclassifies State-Licensed Medical Marijuana](https://cedclinic.com/justice-department-medical-marijuana-reclassification/) Learn about recent federal reclassification efforts impacting medical marijuana and patient access. [Learn More](https://cedclinic.com/justice-department-medical-marijuana-reclassification/) [Cannabis Research](https://cedclinic.com/pediatric-cannabis-certification-care-children/): A Pathway to Better Health Understand how [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) is evolving beyond science to improve health outcomes and policy. Discover More ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).